This position paper describes a model for the future that would provide appropriate standardization, facilitate drug registration and support regulatory agencies.
Neil A. Schwarzwalder
Advertisement
Neil A. Schwarzwalder is a global compendial consultant for the Global Quality Laboratories at Eli Lilly and Company
Articles by Neil A. Schwarzwalder
Advertisement
Latest Updated Articles
- The Ideal Pharmacopeia
Published: November 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
Challenges for the Global Manufacturing of Vaccines
4
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
5
